“G” is the street name for gamma-hydroxybutyric acid, better known as GHB. It is a central nervous system depressant that occurs naturally in the human brain in tiny amounts but, when taken recreationally at much higher doses, produces euphoria, sedation, and disinhibition. GHB gained notoriety in the 1990s as a club drug and as one of the substances linked to drug-facilitated sexual assault, and it remains tightly controlled in most countries. The gap between a dose that feels pleasant and one that causes unconsciousness is dangerously small, which is a big part of why the drug keeps showing up in emergency departments.
What GHB Actually Is
GHB is a short-chain fatty acid that your brain produces on its own as a byproduct of GABA, the main inhibitory neurotransmitter. In that natural form, it floats around at very low concentrations and plays a modest role in regulating sleep and neural signaling. The drug version is the same molecule delivered at far higher levels, typically swallowed as a clear, slightly salty liquid, though it also comes as a powder or capsule. Because your body already makes GHB, it is rapidly metabolized and cleared, which creates real problems for detection if someone needs to prove exposure after the fact.
The dual identity of GHB matters. At the micromolar concentrations your brain normally sees, it interacts with its own dedicated receptor. At the much higher millimolar concentrations produced by a recreational dose, it activates GABA-B receptors throughout the brain, producing the sedation, muscle relaxation, and eventual unconsciousness that define its pharmacological profile. Many of the drug’s clinical and addictive properties appear to run through that GABA-B pathway rather than the body’s natural GHB receptor system.1PubMed. From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid2PubMed. Mechanisms for the Specific Properties of γ-Hydroxybutyrate in Brain
GBL and 1,4-Butanediol Are Not Separate Drugs
Two other chemicals are essentially GHB in disguise. Gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) are industrial solvents that your body rapidly converts into GHB after ingestion. Both circulate on illicit markets, sometimes sold under the same “G” label or as cleaning products and solvents that buyers repurpose. Because they are legal in some jurisdictions for industrial use, they can be easier to obtain than GHB itself.
Despite converting to the same end molecule, GBL and 1,4-BD are not pharmacologically identical to swallowing GHB directly. The speed and completeness of conversion vary, which changes how quickly effects hit and how long they last. One study comparing equimolar doses of all three substances found that 1,4-BD and GBL shared only some of GHB’s behavioral effects, likely because the rate of metabolic conversion shapes the drug experience in ways a simple dose calculation cannot predict.3PubMed. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration 1,4-BD, for instance, is converted to GHB via alcohol dehydrogenase, the same enzyme that processes drinking alcohol. In a clinical study, blocking that enzyme with the drug fomepizole slashed peak GHB blood levels roughly fivefold after a 1,4-BD dose.4PubMed Central. Butanediol conversion to gamma-hydroxybutyrate markedly reduced by the alcohol dehydrogenase blocker fomepizole That detail is more than academic: if someone shows up in an emergency room having swallowed 1,4-BD, the treatment considerations differ from straight GHB exposure.
The Narrow Window Between Euphoria and Unconsciousness
GHB’s danger comes less from its peak toxicity and more from how little room there is between a “fun” dose and a life-threatening one. At blood levels around 100 milligrams per liter, users typically feel euphoric and socially uninhibited. At roughly 500 milligrams per liter, the drug can kill through cardiorespiratory depression.5PubMed Central. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome That fivefold gap might sound comfortable, but because street GHB is a liquid with wildly inconsistent concentration, measuring a dose with any precision is almost impossible. A few extra milliliters can push someone from a pleasant buzz to a deep, vomit-prone coma.
The effects at lower doses include relaxation, mild euphoria, heightened sociability, and increased sexual arousal. As dose increases, slurred speech and drowsiness set in, followed by nausea, loss of motor control, and eventually deep unconsciousness. Vomiting while unconscious is one of the primary ways GHB kills, because the person cannot protect their own airway.
Mixing With Alcohol Makes Everything Worse
GHB and alcohol are both central nervous system depressants that amplify each other’s effects in a way that is genuinely dangerous rather than merely additive. In a controlled study that gave participants GHB and ethanol both separately and together, blood oxygen saturation dropped the most when both drugs were combined, with the effect reaching statistical significance well beyond either substance alone.6PubMed Central. GHB and Ethanol Effects and Interactions in Humans In practical terms, that means a dose of GHB that would be survivable on its own can become lethal if someone has been drinking. Because the two substances are often consumed in the same nightlife environments, this is not a theoretical risk. Emergency physicians consistently report that the most severe GHB cases involve co-ingestion of alcohol or other depressants.
What Happens in a GHB Overdose
The hallmark of GHB poisoning is rapid-onset loss of consciousness. In a large emergency department series of 505 consecutive GHB-related presentations, roughly three-quarters of patients arrived with significantly reduced consciousness. About a quarter required active treatment. There were no deaths in that series, which reflects the fact that with supportive hospital care, most people survive acute GHB intoxication.7PubMed. Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients The problem is what happens before someone reaches a hospital, particularly aspiration of vomit and respiratory depression in unmonitored settings.
There is no reliable antidote for GHB overdose. In that same series, an antidote was tried in 35 cases and produced no response. Management is therefore supportive: protect the airway, monitor breathing and heart rate, treat slow heart rate with atropine if needed, and manage any co-ingested substances.8Annals of Emergency Medicine. A Tale of Novel Intoxication: A Review of the Effects of γ-hydroxybutyric Acid With Recommendations for Management Most patients wake up within a few hours as the drug is metabolized, sometimes abruptly, going from deeply unconscious to alert and oriented in a surprisingly short window.
GHB Dependence and Withdrawal
One of the most underappreciated aspects of GHB is that chronic heavy use creates a dependence syndrome that can produce genuinely dangerous withdrawal. The pattern that sets up severe dependence involves dosing every one to three hours around the clock, including through the night. People in that cycle are essentially never sober. When they stop abruptly, withdrawal symptoms typically begin within hours and include anxiety, insomnia, and tremor. In severe cases, these can progress to full delirium with unstable blood pressure and heart rate.9PubMed. Gamma-hydroxybutyrate withdrawal syndrome
The withdrawal profile shares features with alcohol and benzodiazepine withdrawal, which makes sense given GHB’s action on GABA-B receptors. Common symptoms include sweating, restlessness, and muscle twitching. However, one study that tracked GHB withdrawal under medical supervision noted that severe complications like seizures and hallucinations were rare in their sample, probably because the tapering protocol dampened overall severity.10PubMed Central. Characterization of the GHB Withdrawal Syndrome Case reports of unsupervised withdrawal paint a grimmer picture, with delirium, dangerous swings in blood pressure, and even rhabdomyolysis (breakdown of muscle tissue) appearing in some patients.11PubMed. Severe gamma-hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series
Benzodiazepines are the standard first-line treatment for GHB withdrawal, but they do not prevent all complications. Baclofen, which acts on the same GABA-B receptors that GHB stimulates, has shown promise as an add-on. In one case report, a patient whose seizures and delirium were not controlled by benzodiazepines improved significantly once baclofen was added, allowing clinicians to taper GHB without further neurological crises.12PubMed Central. Baclofen and Gamma-Hydroxybutyrate Withdrawal A randomized trial protocol has been designed to formally test whether baclofen preloading before detoxification reduces the severity of withdrawal and the need for intensive care.13PubMed Central. Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial The bottom line for anyone considering quitting heavy GHB use is that medical supervision matters. Cold-turkey cessation after around-the-clock use is not just uncomfortable; it can be medically dangerous.
GHB Has a Legitimate Medical Use
For all its notoriety as a recreational substance, GHB is also an FDA-approved prescription drug sold under the brand name Xyrem (sodium oxybate). Its approved use is for narcolepsy, specifically for reducing cataplexy (sudden muscle weakness triggered by emotions) and excessive daytime sleepiness.14The Lancet Child & Adolescent Health. Safety and efficacy of sodium oxybate in paediatric patients with narcolepsy with cataplexy This might seem paradoxical for a drug associated with knocking people out at parties, but GHB’s ability to consolidate deep sleep is exactly what narcolepsy patients need. Their sleep architecture is fragmented, and a controlled nighttime dose taken in two divided portions helps them achieve the restorative sleep stages that improve daytime functioning.
A systematic review of randomized trials found that sodium oxybate at typical doses reduced weekly cataplexy attacks by a clinically meaningful margin and improved objective measures of daytime wakefulness compared to placebo.15PubMed Central. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis A separate analysis tracking time to response found that cataplexy responded relatively quickly, with a median time to first improvement around 25 days, while excessive daytime sleepiness took longer at around 37 days. Maximum benefit for sleepiness took several months to fully develop.16PubMed Central. Time to Response with Sodium Oxybate for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy
Xyrem is distributed through a restricted program precisely because of the drug’s abuse potential. Prescriptions go through a single centralized pharmacy, and both patients and physicians must register. The existence of this tightly controlled medical channel underscores a broader point about GHB: the molecule itself is pharmacologically interesting and genuinely useful, but the margin of safety and the addiction potential make it hazardous outside a clinical framework.
Why GHB Is So Hard to Detect
GHB creates a forensic headache that few other drugs match. It is eliminated from the body rapidly, it exists naturally in small amounts in everyone’s system, and it can even form in biological samples after collection through bacterial action. Together, these characteristics mean that by the time a suspected victim of drug-facilitated assault reaches a hospital and has blood or urine drawn, the window for detecting an exogenous dose may already have closed.17PubMed Central. Endogenous Levels, Detection Time, and Symptoms of Gamma-Hydroxybutyric Acid: Results From a Placebo-Controlled Clinical Trial
Standard urine drug screens do not test for GHB at all. Specialized assays can detect it, but they need to distinguish between endogenous (naturally produced) and exogenous (drugged) levels, and the cutoff values for making that distinction remain a subject of debate among toxicologists. Hair analysis can extend the detection window to weeks, but it requires specialized laboratory capability that is not widely available. The rapid elimination and the analytical challenges are among the reasons GHB earned its reputation as an “invisible” drug in sexual assault cases.18PubMed Central. Extended Detection Window for Gamma-Hydroxybutyrate in the Urine of an Elderly Woman
From Anesthetic to Supplement to Schedule I
GHB’s history is a strange arc. It was first synthesized in the early 1960s as a potential anesthetic, and it saw some clinical use in Europe in that role. By the 1980s, it had migrated into an entirely different market: bodybuilding. The theory was that GHB stimulates growth hormone release, and it was sold over the counter in the United States as a dietary supplement for gym-goers looking to put on lean muscle.19PubMed Central. Toxicological Characterization of GHB as a Performance-Enhancing Drug Bodybuilders were essentially the early adopters who introduced GHB into recreational drug culture before it spread into clubs and raves in the 1990s.
The drug’s association with sexual assault accelerated regulatory action. In 2000, the Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act placed GHB on Schedule I of the Controlled Substances Act in the United States, making possession without a prescription a federal crime.20ACS Chemical Neuroscience. DARK Classics in Chemical Neuroscience: Gamma-Hydroxybutyrate (GHB) The unusual twist is that the pharmaceutical formulation, sodium oxybate, sits on Schedule III when prescribed for narcolepsy, making GHB one of the rare substances that lives in two different scheduling categories depending on context.
GHB in Chemsex and Club Subcultures
GHB occupies a particular niche in sexual and nightlife subcultures that other depressants do not fill in the same way. Its disinhibiting and euphoric effects at low doses, combined with heightened tactile sensation, have made it a fixture in chemsex settings, where drugs are used specifically to facilitate extended sexual encounters. Research conducted among gay men in New York City found that participants identified GHB as their most frequently used club drug, and that its appeal persisted despite their awareness of potential adverse outcomes, including overdose risk and dependence.21PubMed Central. A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes
Understanding this context matters for public health outreach, because GHB harm reduction cannot follow the same playbook as, say, opioid harm reduction. The drug is taken in social and sexual settings where precise dosing is difficult, re-dosing is common, and alcohol is often present. Education efforts in these communities have increasingly focused on practical strategies like not mixing with alcohol, using a measured syringe rather than eyeballing liquid doses, and setting phone alarms to avoid re-dosing too soon. Whether these strategies reduce overdose rates at a population level remains an open question, but they reflect a pragmatic acknowledgment that some people will use the drug regardless of its legal status.